Ourania Tatsis
CIK 1789815 · EVP, Chief Reg. & Quality Off. · last filed 2026-05-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$20.92M
Companies
3
Total Filings
52
Lifetime Open-Market Net
-$20.57M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Recent Filings · Page 2 of 6
52 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-03-12 | VRTX | Sell (S) | −3,242 | -$1.62M | EDGAR |
| 2025-03-06 | VRTX | Sell (S) | −4,058 | -$1.97M | EDGAR |
| 2025-02-28 | VRTX | Mixed | −5,492 | -$2.63M | EDGAR |
| 2025-02-26 | VRTX | Mixed | −3,664 | -$1.77M | EDGAR |
| 2025-02-19 | VRTX | Mixed | −2,537 | -$1.17M | EDGAR |
| 2025-02-14 | VRTX | Grant (A) | +6,211 | $0 | EDGAR |
| 2025-02-12 | VRTX | Mixed | −2,453 | -$1.15M | EDGAR |
| 2025-02-06 | VRTX | Grant (A) | +17,376 | $0 | EDGAR |
| 2024-06-28 | Verve Therapeutics, Inc. (VERV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-06-05 | VRTX | Sell (S) | −2,175 | -$1.00M | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.